Literature DB >> 7082957

Cimetidine and perforated peptic ulcer.

A J McKay, C S McArdle.   

Abstract

Cimetidine is thought to have accelerated the reduction in elective peptic ulcer surgery but its effect on the incidence of perforated peptic ulcer has not been reported. A 15-year (1966-1980) review of peptic ulcer surgery in a district general hospital is presented. Since cimetidine became available (November 1976), the mean annual number of elective operations has fallen from 91.4 to 50.5 (45 per cent reduction). The number of perforations has fallen from 40.6 to 36.5 (10 per cent reduction). One hundred and five patients treated for perforation (97 duodenal, 8 gastric) from 1978 to 1980 were reviewed in detail. Of the 64 patients with a chronic ulcer, 8 were taking cimetidine when their ulcers perforated and a further 8 had been on the drug previously. Cimetidine has substantially reduced elective peptic ulcer surgery. There appears to have been no equivalent reduction in the incidence of perforation.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7082957     DOI: 10.1002/bjs.1800690609

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  11 in total

Review 1.  Asymptomatic peptic ulcer disease. Is it worth looking for?

Authors:  R Corinaldesi; R De Giorgio; A Paternicò; V Stanghellini
Journal:  Drugs       Date:  1991-06       Impact factor: 9.546

2.  Perforated duodenal ulcers.

Authors:  J Boey; J Wong
Journal:  World J Surg       Date:  1987-06       Impact factor: 3.352

Review 3.  Long term treatment of duodenal ulcer. A review of management options.

Authors:  G Bianchi Porro; F Parente
Journal:  Drugs       Date:  1991-01       Impact factor: 9.546

4.  Can restrictions on reimbursement for anti-ulcer drugs decrease Medicaid pharmacy costs without increasing hospitalizations?

Authors:  D M Cromwell; E B Bass; E P Steinberg; Y Yasui; W J Ravich; T R Hendrix; S F McLeod; R D Moore
Journal:  Health Serv Res       Date:  1999-02       Impact factor: 3.402

5.  [Perforation: which therapy is proven in stomach ulcer and duodenal ulcer?].

Authors:  M Rothmund; W Pitsch
Journal:  Langenbecks Arch Chir       Date:  1985

6.  Duodenal ulcer perforation: the effect of H2 antagonists?

Authors:  P Gillen; W Ryan; A L Peel; H B Devlin
Journal:  Ann R Coll Surg Engl       Date:  1986-09       Impact factor: 1.891

7.  Perforated gastric ulcer.

Authors:  J Wilson-Macdonald; N J Mortensen; R C Williamson
Journal:  Postgrad Med J       Date:  1985-03       Impact factor: 2.401

8.  Highly selective vagotomy in duodenal ulceration and its complications. A 12-year review.

Authors:  T F Gorey; F Lennon; S J Heffernan
Journal:  Ann Surg       Date:  1984-08       Impact factor: 12.969

9.  Proximal gastric vagotomy. The preferred operation for perforations in acute duodenal ulcer.

Authors:  J Boey; F J Branicki; T T Alagaratnam; P J Fok; S Choi; A Poon; J Wong
Journal:  Ann Surg       Date:  1988-08       Impact factor: 12.969

10.  Incidence of perforated and bleeding peptic ulcers before and after the introduction of H2-receptor antagonists.

Authors:  A Christensen; R Bousfield; J Christiansen
Journal:  Ann Surg       Date:  1988-01       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.